Objectives: Rapid detection of the plasmid-mediated quinolone resistance determinant AAC(6 0 )-Ib-cr in Enterobacteriaceae by measuring acetyltransferase activity against fluoroquinolones by MALDI-TOF MS analysis.
Introduction
Fluoroquinolones (FQs) are among the most frequently prescribed antimicrobial agents worldwide. FQ resistance (FQR) occurs mainly as a result of mutations in chromosomal genes encoding the quinolone targets DNA gyrase and topoisomerase IV. 1 Three plasmid-mediated quinolone resistance (PMQR) mechanisms have also been described: (i) the Qnr proteins, which protect the quinolone targets; (ii) the AAC(6 0 )-Ib-cr enzyme; and (iii) QepA and OqxAB plasmid-mediated efflux pumps. 2 The second plasmid-mediated mechanism involves acetylation of quinolones with an appropriate amino nitrogen target (ciprofloxacin and norfloxacin) by a variant of the common aminoglycoside acetyltransferase AAC(6)-Ib. 3 These plasmid-mediated mechanisms provide only low-level resistance that by itself does not exceed the clinical breakpoint for susceptibility, but nonetheless facilitates selection of higher-level resistance during treatment and makes infection by pathogens containing PMQR harder to treat. 4 Furthermore, the emergence of a very close association between quinolone resistance and resistance to other antimicrobial agents, particularly b-lactams (generally mediated by extended-spectrum b-lactamases) and aminoglycosides, is a critical problem in managing these infections. [5] [6] [7] [8] [9] In the case of isolates harbouring PMQR, but lacking FQR mutations, molecular tests are needed to detect these determinants, as there are no specific phenotypic tests for the detection of PMQR mechanisms. 10 In the present study, we proposed a rapid MALDI-TOF-MS-based method for detecting the AAC(6 0 )-Ib-cr enzyme by measuring acetyltransferase activity against ciprofloxacin, norfloxacin and levofloxacin. Acetylation corresponds to a mass shift of 43 Da, which can be easily detected by MALDI-TOF MS after 30 min of incubation of the bacteria to be tested with the given antibiotic.
MALDI-TOF MS has become an established tool for the rapid identification of microorganisms in microbiological laboratories. [11] [12] [13] [14] The technique has recently proved useful for detecting b-lactamase activity with good results. [15] [16] [17] [18] [19] [20] The presence study highlights the ability of MALDI-TOF MS to detect resistance determinants other than b-lactamases, by applying this methodology to the AAC(6 0 )-Ib-cr enzyme, which is the most prevalent plasmid-mediated quinolone resistance mechanism in Enterobacteriaceae. 5, 6 Materials and methods
Bacterial isolates
As a preliminary step to optimize the method, we tested a collection of 81 previously studied isogenic Escherichia coli control strains (all derived from E. coli ATCC 25922, which is used worldwide for susceptibility testing) carrying combinations of four chromosomally mediated quinolone resistance mechanisms (including modifications in gyrA and parC or marR deletion), plasmid-mediated qnr and aac(6 0 )-Ib-cr genes, or the plasmidmediated QepA2 efflux pump (Table S1 , available as Supplementary data at JAC Online). 21 Out of the 81 isolates, 10 were AAC(6 0 )-Ib-cr producers. In the second part of the study we evaluated the optimized procedure in a series of 36 blinded clinical isolates previously characterized with respect to FQR, 25 of them carrying the AAC(6 0 )-Ib-cr enzyme with and without other resistance mechanisms attached (including modifications in gyrA and parC and carrying plasmid-mediated qnr). Among them, 14 were E. coli and 22 were Klebsiella pneumoniae, obtained from a previous multicentre collection (Table S2) . 6 
MALDI-TOF MS acetylation assay
The above-mentioned E. coli isogenic control strains were grown overnight in trypticase soy agar (TSA) with 5% sheep blood (Becton Dickinson, NY, USA). The assay was performed as described by Sparbier et al. 15 Briefly, for analysis of bacteria, a 1 lL loop of bacteria was resuspended in 50 lL of reaction buffer and incubated at 37 C for 30 min. Bacteria were evaluated simultaneously in three different solutions containing ciprofloxacin (0.50 mg/mL, Sigma-Aldrich, Germany), norfloxacin (0.50 mg/mL, SigmaAldrich) and levofloxacin (0.50 mg/mL, Sigma-Aldrich). The antibiotics had previously been dissolved in 0.1 M HCl and were diluted to the final concentration in a buffer containing 10 mM NH 4 HCO 3 and 0.01% SDS to a final pH of 6.5. The clinical isolates were evaluated in the same way.
MALDI-TOF MS analysis
For MALDI-TOF MS measurements for detection of the AAC(6 0 )-Ib-cr enzyme, duplicate samples (1 lL) of the supernatant obtained after incubation of the bacterial pellet with the antibiotic were spotted directly onto a polished steel MALDI target plate. Dried spots were overlaid with 1 lL of MALDI-TOF matrix (10 mg/mL a-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile and 0.1% trifluoroacetic acid (Bruker Daltonik GmbH, Germany)]. Spectra were acquired in a MALDI Microflex LT/SH bench-top mass spectrometer (Bruker Daltonik) equipped with a 60 Hz nitrogen laser in the mass range between 100 and 1000 Da, with a mass peak resolution .300 by employing an optimized acquisition method using FlexControl v. 3.0 software.
Data evaluation for detection of AAC(6 0 )-Ib-cr enzyme
The acquired MALDI-TOF MS spectra were analysed with the software Flexanalysis v. 3.3 (Bruker Daltonik). Spectra were smoothed and the baseline was subtracted (algorithm, TopHat). Peaks were manually selected with the following parameter settings: peak detection algorithm, snap; signal-to-noise threshold, 4; relative intensity threshold, 0%; minimum intensity threshold, 100; peak width, 0.2 m/z; height, 80%; baseline subtraction, TopHat. The effect of acetylation yields an increase of 43 Da in the mass of ciprofloxacin and norfloxacin, but not of levofloxacin ( Figure 1 ). The acetylation reaction could thus be detected by MS. Only peaks belonging to the corresponding antibiotic drug and the respective acetylation products were labelled. Since no automated data evaluation software was available at this time, classification as susceptible and resistant was done by visual inspection of the mass peaks in the spectra. In order to achieve this, the peak intensities of the acetylated forms were compared with the intensities of the non-acetylated forms. Isolates were classified as negative for AAC(6 0 )-Ib-cr if the intensity distributions of the antibiotic analysed were similar to those for the negative control. Isolates were classified as AAC( 6 0 )-Ib-cr positive if the intensities of the acetylated forms represented 50% or more of the intensities compared with the non-acetylated forms.
Results

MS analysis of FQs with the isogenic E. coli control strains
As a preliminary step to analyse the mass spectra of ciprofloxacin, norfloxacin and levofloxacin, a collection of 81 previously studied isogenic E. coli control strains (derived from E. coli ATCC 25922) was used, as this represents a consistent and reliable model for measuring the AAC(6 0 )-Ib-cr enzyme activity. The MS spectrum corresponding to ciprofloxacin revealed the molecular ion peak [ Figure 3 shows representative spectra of the acetylated and nonacetylated forms of norfloxacin.
Following MS analysis, isolates 12-21 (Table S1 ) carrying the AAC(6 0 )-Ib-cr resistance determinant showed enzymatic activity against both ciprofloxacin and norfloxacin. The negative controls showed no activity against the antibiotics. Isolates carrying resistance mechanisms other than the AAC(6 0 )-Ib-cr enzyme did not alter the appearance of the mass peaks described above, which remained unchanged regardless of how the modification was conferred: either chromosomally mediated quinolone resistance mechanisms (including modifications in gyrA and parC or marR deletion) or the plasmid-mediated qnr.
The MS spectrum corresponding to levofloxacin revealed the molecular ion peak [ Table 1 ). The spectra of the supernatants obtained after 30 min of incubation of the AAC(6 0 )-Ib-cr-producing isogenic E. coli control strains revealed no additional peaks corresponding to the acetylated forms as expected.
3 Figure 4 shows representative spectra of levofloxacin.
The MS spectra of the FQs analysed identified the molecular ion peak as the most intense, with the sodium adduct and the potassium adduct being less intense in turn. This was similar for the corresponding acetylated forms of ciprofloxacin and norfloxacin, resulting in the potassium adduct peak occasionally being detected. A clear differentiation between AAC(6 0 )-Ib-cr-producing isolates and non-AAC(6 0 )-Ib-cr-producing isolates was thus possible by comparing the observed peak patterns for the modified antibiotics, after an incubation time of 30 min. A shorter incubation time did not result in a clear differentiated peak pattern.
Identification of the AAC(6 0 )-Ib-cr-positive clinical isolates
The MALDI-TOF-MS-based assay for the detection of acetylation of ciprofloxacin and norfloxacin and non-acetylation of levofloxacin was validated using a collection of 36 clinical isolates (Table S2 ). Oviaño et al.
Aac(6′)-lb-cr
In the case of AAC(6 0 )-Ib-cr-producing isolates, the characteristic peak pattern, which was described above for the isogenic E. coli control strains, was also found. The intensities of the acetylated forms and the non-acetylated forms were found to be in the same range of magnitude within the same spectrum, with the AAC(6 0 )-Ib-cr-producing isolates more similar to those of the positive controls. None of the isolates tested showed a total disappearance of the non-acetylated forms, with both acetylated and nonacetylated forms coexisting in the same spectrum. A prolonged incubation time with the respective antibiotics did not lead to detection of acetylated forms only. This bears out that the AAC(6 0 )-Ib-cr acetyltransferase enzyme only confers a low level of resistance in agreement with the enzymatic kinetics and the MIC expressed by these isolates previously studied. 3, 6 Five out of the 11 isolates that had the AAC(6 0 )-Ib enzyme with no resistance adaptation for modifying FQs showed no mass peaks belonging to the acetylated forms. The rest of the isolates showed very low intensity peaks for the acetylated form, of approximately 10% of the intensities of the non-acetylated forms. Levofloxacin was found intact in all isolates tested, with no apparent modification of the chemical structure, as it was for the controls. The sensitivity and specificity of the MALDI-TOF-MS-based method described above were therefore 100% for a 30 min assay.
Discussion
Successful MALDI-TOF-MS-based analysis of bacteria to determine their susceptibility or resistance to b-lactam antibiotics has recently been reported. [15] [16] [17] [18] [19] [20] The measurement of small molecules such as antibiotics by MALDI-TOF MS is a relatively new application of the technology. Our data support that this technique is not only suitable for b-lactam antibiotics, but also for FQs and in the future possibly for other families of antibiotics.
Here, we describe the mass spectrometric analysis of the activity of the AAC(6 0 )-Ib-cr acetyltransferase plasmid-associated gene that encodes a variant of a common aminoglycoside acetyltransferase that is capable of acetylating and reducing the activity of certain FQs, such as ciprofloxacin and norfloxacin, but (c) Figure 2 . MALDI-TOF MS spectra of ciprofloxacin. MALDI-TOF MS spectra of ciprofloxacin after incubation with the negative control E. coli ATCC 25922 (a), an AAC(6 0 )-Ib-cr enzyme producer (E. coli, isolate 21; Table S1 ) (b) and a non-AAC(6 0 )-Ib-cr enzyme producer (E. coli, isolate 11; Table S1 ) (c). Peaks corresponding to the acetylated form of ciprofloxacin are indicated with an arrow.
Detection of AAC(6 0 )-Ib-cr-producing Enterobacteriaceae by MALDI-TOF MS JAC not levofloxacin. Although the degree of resistance conferred is small, this mechanism has been shown to act additively with another resistance mechanisms for FQs, and is associated with other types of resistance mechanisms such as extendedspectrum b-lactamases.
6,22
In contrast to the molecular methods usually used to detect this type of resistance, the MALDI-TOF-MS-based method described here delivers results after only 30 min. 23, 24 Another advantage of this method is its relative affordability. It is also easy to develop, and within reach for many clinical microbiology laboratories. Furthermore, the interpretation of the spectra is reasonably simple, once the assignment of mass peaks has been performed, and the procedure may be automated, as it has been done for b-lactam antibiotics. 25 Following validation using a clinical cohort comprised of 36 clinical isolates, the sensitivity and specificity of the MALDI-TOF MS assay for detection of AAC(6 0 )-Ib-cr enzyme carriers were determined to be 100%. Evaluation of the different antibiotics in this manner led us to conclude that use of either ciprofloxacin or norfloxacin as a resistance marker in MS will lead to no differences. Although the MICs of norfloxacin are superior to those of ciprofloxacin when the AAC(6 0 )-Ib-cr enzyme is present, we have not observed an increased degree of acetylation during exposure to norfloxacin by MS. 3, 6, 22 A future automation of the assay could provide clear answers in this field. Levofloxacin may be useful as a negative control in such an assay.
Although the AAC(6 0 )-Ib-cr acetyltransferase enzyme confers only a low level of resistance, well below the cut-off for clinical resistance (either CLSI or EUCAST), the MALDI-TOF MS assay described herein is able to detect it accurately with 100% agreement compared with molecular techniques.
The presence of very-low-intensity acetylated peaks observed in isolates producing the AAC(6 0 )-Ib enzyme with no resistance adaptation for modifying FQs could indicate that a residual acetylation of ciprofloxacin and norfloxacin is possible. However, this fact cannot be considered significant as these peaks had very low intensities compared with those due to the isolates producing AAC(6 0 )-Ib-cr, and were thus easily distinguishable. Besides, by (c) Figure 3 . MALDI-TOF MS spectra of norfloxacin. MALDI-TOF MS spectra of norfloxacin after incubation with the negative control E. coli ATCC 25922 (a), an AAC(6 0 )-Ib-cr enzyme producer (E. coli, isolate 21; Table S1 ) (b) and a non-AAC(6 0 )-Ib-cr enzyme producer (E. coli, isolate 11; Table S1 ) (c). Peaks corresponding to the acetylated form of norfloxacin are indicated with an arrow. Oviaño et al. employing the data evaluation algorithm proposed herein, these mass peaks would not be even classified as AAC(6 0 )-Ib-cr positive. No relationship between these isolates and the level of expression could be detected in this manner. Furthermore, the presence of other resistance mechanisms associated with FQR had no impact on the results obtained.
The concentrations of antibiotics used for the MALDI-TOF MS assay are much higher than the concentrations used for the phenotypic assays, 15 as lower antibiotic concentrations would lead to poor-quality spectra. However, this does not impact the results as isolates carrying the AAC(6 0 )-Ib-cr enzyme would acetylate the substrate in any case, resulting in clearly different spectra between the non-acetylated and acetylated forms.
In conclusion, MALDI-TOF MS is an outstanding method for the detection of the AAC(6 0 )-Ib-cr enzyme in clinical samples. The method is easy to perform and results can be obtained within 30 min. This novel application of MALDI-TOF MS broadens the potential of this technology, expanding the capacity of MALDI-TOF MS analysis into new families of antibiotics, in which resistance is promoted by enzymatic modification of the antibiotic. Table S1 ) (b) and a non-AAC(6 0 )-Ib-cr enzyme producer (E. coli, isolate 11; Table S1 ) (c).
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